Navigation Links
St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection

BioCryst Says Study Confirms and Extends Evidence Seen in a Previous Study

BIRMINGHAM, Ala., May 02, 2007 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. today announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam). The study, presented on April 30, 2007 by Dr. David Boltz at the 20th International Conference on Antiviral Research, Palm Springs, CA, concluded that peramivir is an effective treatment when administered intramuscularly to control H5N1 infection in mice and that these data support the potential use of this drug to control influenza in the event of a pandemic.

The objective of the study was to achieve complete protection against lethal H5N1 influenza virus infection in the mouse model through the use of intramuscular administration of peramivir, a potent neuraminidase inhibitor with antiviral activity against strains of influenza viruses, including seasonal strains and influenza H5N1 strains from avian origins.

A survival rate of 40% to 60% was observed in mice treated with one or two injections of peramivir; however, 100% survival of mice was achieved by two injections of peramivir on the first day followed by once-daily administration for 7 days. The longer duration of peramivir treatment also prevented viral replication in the tissues of the lungs, brain and spleen of the mice at the 3, 6, and 9 day post-inoculation time points.

W. James Alexander, MD, MPH, BioCryst Senior Vice President for Clinical Operations commented, "The results of this St. Jude study, performed under the careful guidance of Drs. Elena Govorkova and Robert Webster, bolsters our confidence that peramivir may be clearly beneficial in the treatment of severe i
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
(Date:11/6/2009)..., MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstC..., a leading specialty pharmaceutical company, anno...nd chief executive officer, will provide an overvi...dit Suisse 18th Annual Healthcare Conference on We...ndard Time. ,, This presentation will be webcas...
(Date:11/6/2009)..., WESTBURY, N.Y., Nov. 6 Repo...nd machine tools in the third quarter of 2009 decl...ording to Nassau Asset Management,s NasTrac Quarte...pany,s activity reports for both repossessions and...possessions for both construction and printing equ...
(Date:11/6/2009)..., DETROIT, Nov. 6 C...: CPD ) has launched ketorolac tromethamine ophth...om the US Food and Drug Administration (FDA) for S...) for generic Acular® ophthalmic solution on ...rength of ketorolac is therapeutically equivalent ...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 1CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 2Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 1Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 2Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 3Shamir Optical Industry Ltd to Host Conference Call Announcing Second Quarter of 2009 Earnings Results 53823 1Shamir Optical Industry Ltd to Host Conference Call Announcing Second Quarter of 2009 Earnings Results 53823 2
...ELTON, Conn., Sept. 2 Vivatone(R) Hearing Systems... new open-ear hearing,device., Hearing aids tradi...he,ear canal, causing a person,s voice to sound li... revolutionized the hearing aid industry in April,... aid. Vivatone(R),s small,microphone and digital s...
...Presented at the Annual ESC Congress 2008, Munich,...ults from a new landmark trial of purified n-3,pol...d at one of the,worlds, largest cardiology meeting... reduced mortality and hospital admissions for car...eart failure(1)., GISSI-HF was a 3.9 year prospec...
Other Medicine Technology:Unique Hearing Aid Receives Patent Protection 2n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure 2n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure 3n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure 4n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure 5n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure 6
(Date:11/8/2009)... Straight-back, chest-out position promotes self-...v. 8 (HealthDay News) -- Your mother may have been...esearch suggests that good posture could make you ...st of us were taught that sitting up straight give...y, co-author of the study and a psychology profess...
(Date:11/8/2009)... , WASHINGTON, Nov. 8 /PRNewswire-USNewswire/...ld a press conference following the House passage ...ca Act. The bill passed by a vote of 220 to 215. ...I and some of my colleagues just received a call f...ma, congratulating us on a great victory for the A...
(Date:11/8/2009)... , Freeze-drying of bioph...;s Mississauga, Ontario facility. , ...- Thomas Wellner, President and CEO of Therapure B... taken delivery of a commercial scale pharmaceutic...al scale freeze drying (lyophilization) available ...
(Date:11/8/2009)... , "One victory does not mean the battle is ... Nov. 7 In a vote of 24...r-Lipinski-Smith Amendment to prohibit abortion ma...floor. ,, Americans United for Life Action Pres...ge of this amendment is a victory for the pro-life...
(Date:11/8/2009)... , Calls for Swift Passage of H.R. 3961 to S...v. 7 Statement Attribut...n Medical Association. ,, (Logo: http://www.n... "The AMA hails the passage of the House health re...em for patients and physicians and calls for swift...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
...t should consider Medical Council of India seniori...s Association// for Social Equality' said today. ... Secretary, Dr G R Ravindranath, said according to...ent health services, the government should conside...
..., contrast-enhanced sonography compared with sonog...essment of blunt abdominal trauma.// Massimo ...objective of our study was to prospectively compar...s”. The study was conducted by the departmen...
...ied a novel gene that facilitates the spread of ma...//using a technique they say can speed the discove...ientists from Dana-Farber Cancer Institute, led by...nomas that have not spread. The protein made...
...hat physical inactivity due to lack of recreationa...the surrounding area make rural people obese.// ... the link between obesity and the environmental fa...es of a community that encourage physical activity...
...omyalgia (FM) experience significant pain, fatigue... misdiagnosed// or under treated as a normal part ...aren M. Schaefer, D.N.Sc., R.N., assistant profess... muscles and soft tissues of the body. Many suffer...
...y of Rochester Medical Centre say that the antipsy...de effects. //Clopazine is the most effective anti... last hope for many people. But there are long-ter...amberti, the lead author of the study. The...
Other Medicine News:Health News:New Tool Found to be Effective in Assessing Blunt Abdominal Trauma 2Health News:Researchers have Identified the Gene that Spreads Skin Cancer 2Health News:Environmental Factors Leads to Obesity in Rural Communities 2Health News:Fibromyalgia Increases Pain and Fatigue for Pregnant Women 2
Wide Mini-Sub Cell GT System, 15 x 7 cm tray, mini-gel caster
Large Gel Drying Frame
...Most gels can be dried by positioning them on the ...m with wet semi-permeable cellophane and clamping ...'s Tombs also produce great fluorographs. Order a ...el to be dried. Note our cellophane is less than h...
...Most gels can be dried by positioning them on the ...m with wet semi-permeable cellophane and clamping ...'s Tombs also produce great fluorographs. Order a ...el to be dried. Note our cellophane is less than h...
Medicine Products: